Danielle Sara Applebaum

Danielle Applebaum practices at Elite Dermatology in Katy, Texas.

Danielle Applebaum's NPI, 1073931812, was assigned on March 30, 2014. Danielle Applebaum graduated from Baylor College Of Medicine in 2014. Danielle Applebaum's Texas license number on file is R0687.

Danielle Applebaum's primary practice is Elite Dermatology, at 4603 Farm To Market Rd 1463rd Rd, Katy, TX 77494 in Fort Bend County. The practice phone is (281) 612-0050.

Danielle Applebaum's primary practice is Elite Dermatology in Katy, Texas. The medical group on file is Elite Dermatology & Plastic Surgery. Dmand AI also links Danielle Applebaum to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Danielle Applebaum practices. Vendor and product names are available with a free account.

Dermatology is Danielle Applebaum's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Danielle Applebaum is board certified in dermatology by the American Board of Dermatology. Danielle Applebaum has a license on file in Texas.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, contact dermatitis, corns and calluses, facial skin infection, hives and itchy rashes among the conditions Danielle Applebaum treats.

CMS data shows 567 Medicare services from Danielle Applebaum across 9 procedure codes in 2024, for 119 Medicare patients. Medicare paid $26,808 for them. Every service was in an office.

CMS counts 119 Medicare patients who saw Danielle Applebaum in 2024. The largest group is 65 to 74, with 74 patients. 75% of them have high cholesterol, and 61% have high blood pressure. Their average risk score is 0.97, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Danielle Applebaum's median patient age at 43, with 63% women.

In 2024, Danielle Applebaum wrote 438 Medicare Part D claims for 143 patients. 79% of them were for generic drugs. CMS names the drug for 320 of them, across 11 drugs with 11 or more claims each, at $265,567 in total drug cost. In 2023, CMS named 440 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Danielle Applebaum for performance year 2024, reported as part of a group. Danielle Applebaum accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 142 procedures of removal of skin lesions by Danielle Applebaum, more than 77% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 16 papers to Danielle Applebaum, published from 2013 to 2021. 2017 was the busiest year, with 5. The most frequent topics are Skin Neoplasms, Diagnosis, Differential and Drug Eruptions. Danielle Applebaum has published most often in Dermatol Online J. Danielle Applebaum's most frequent co-authors are Sylvia Hsu, MD, Harry Dao, MD and Victoria Mitre, MD.

CMS Open Payments shows 992 general payments to Danielle Applebaum from 34 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Abbvie Inc. paid the most, $2,783.

Dmand AI lists 2 awards for Danielle Applebaum.

Danielle Applebaum graduated from Baylor College Of Medicine in 2014.

Danielle Applebaum is in network with 18 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.